Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
Title:
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
Author:
Phillips, Tycel J. Bond, David Takiar, Radihka Kump, Karson Kandarpa, Malalthi Boonstra, Philip Mayer, Tera Lynn Nachar, Victoria Wilcox, Ryan A. Carty, Shannon A. Karimi, Yasmin H. Nikolovska-Coleska, Zaneta Kaminski, Mark S. Herrera, Alex F. Maddocks, Kami Popplewell, Leslie Danilov, Alexey V.